EcoDrugPlus

Microtubule Associated Protein Tau

Ensembl ID : ENSPKIG00000023770
Gene Symbol: MAPT
1 Cross references
245 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSPKIG00000012922
Gene Symbol: MAPK1
3 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 1-Like

Ensembl ID : ENSPKIG00000002160
Gene Symbol: LOC111835825
3 Cross references
197 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSPKIG00000024133
Gene Symbol: MAPK10
3 Cross references
20 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSPKIG00000006972
Gene Symbol: MAPK10
3 Cross references
21 Possible Orthologues:

Mitogen-Activated Protein Kinase 11-Like

Ensembl ID : ENSPKIG00000017863
Gene Symbol: LOC111845666
3 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSPKIG00000024422
Gene Symbol: MAPK14
4 Cross references
218 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSPKIG00000008112
Gene Symbol: LOC111835993
2 Cross references
219 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSPKIG00000016683
Gene Symbol: MAPK8
4 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSPKIG00000016402
Gene Symbol: LOC111848368
3 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSPKIG00000019058
Gene Symbol: MAPK9
3 Cross references
148 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSPKIG00000020990
Gene Symbol: MAPK9
3 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).